MarketBeat on MSN
A Trillion-Dollar Pill: Eli Lilly Broke the Healthcare Ceiling
In the last part of November 2025, Eli Lilly and Company (NYSE: LLY) shattered a historic ceiling. The Indianapolis-based ...
Instead of struggling with weekly injections, patients may soon be able to swallow a daily pill to lose weight. Both the ...
Healthcare giant Eli Lilly is now the first global healthcare company to hit $1 trillion in value riding on the popularity of ...
The pharmaceutical company’s success developing medicines for obesity has swelled its worth to levels associated with tech titans like Apple and Google and dwarfed that of its drugmaking peers.
(CNN) — Eli Lilly and Company has filed several lawsuits against certain U.S. medical spas, wellness centers, and compounding pharmacies in an attempt to stop them from “the unlawful marketing and ...
Eli Lilly (NYSE:LLY) is taking the unusual step of asking people who took compounded versions of their drug tirzepatide, marketed as Zepbound for weight loss and Mounjaro for type 2 diabetes, for ...
INDIANAPOLIS (WISH) — LillyDirect is a telehealth platform for some of Lilly’s most popular drugs. The new service marks the first time a pharmaceutical company has gotten this involved in care ...
Eli Lilly sued medical spas, wellness centers and compounding pharmacies over counterfeit versions of its diabetes drug Mounjaro (tirzepatide). In a statement released Tuesday afternoon, Lilly said it ...
Eli Lilly & Co. is bringing a pharmaceutical startup incubator to 2300 Market St. MCB Science + Health has finished the ...
Since the first biotech incubator site opened in 2019, participating startups have collectively raised more than $3 billion.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results